Stepping up its attack on the Narendra Modi government over the three farm laws, the Congress on Saturday said the Prime Minister should resign if he can’t repeal the laws and has to depend on the Supreme Court to break the deadlock with farmers.
More than a hundred members of the British Parliament have signed a letter to British Prime Minister Boris Johnson asking him to raise the concerns of protesting farmers outside Delhi, and the “brute force” employed against them, in his discussion with Prime Minister Narendra Modi
Just three months after its formation, J&K s regional amalgam, the Peoples Alliance for Gupkar Declaration (PAGD) that was stitched to fight for the return of pre-August 5, 2019 status, has been rocked by opposition within, with several top leaders pitching against its continuation.
More COVID cases should be tested for genome sequencing, says virologist ANI | Updated: Jan 01, 2021 22:59 IST
New Delhi [India], January 1 (ANI): With the cases of the new variant of the strain of coronavirus having gone up to 25 in India, a Delhi-based virologist has suggested that there should be more genome sequencing of positive cases.
The new variant found in the United Kingdom is known to spread faster.
Dr Shahid Jameel, virologist and director, Trivedi School of Biosciences in Delhi said the country has reported a total of over 10 million COVID-19 cases and noted that a fast-spreading variant does not have to come from outside.
More COVID cases should be tested for genome sequencing theuknews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theuknews.com Daily Mail and Mail on Sunday newspapers.
PM warns of need for vigilance with intervention
V.G. Somani, Drug Controller General India (DCGI), at a webinar on Thursday indicated that India was close to approving a COVID-19 vaccine.
Mr. Somani was participating in a webinar, organised by the Department of Biotechnology, that saw vaccine experts, infectious disease experts and representatives of companies developing vaccines discussing COVID vaccine development and India’s preparation.
“We will probably have a Happy New Year with something in hand,” he said while discussing the regulatory process as well as the participation by academicians, industry and infectious disease experts in working towards developing vaccine candidates.